EUVIMEDEUVIMED entdecken
Klinische Studie

Efficacy of radiolabelled PD-L1-targeted nanobody in predicting and evaluating the combined immunotherapy and chemotherapy for resectable non-small cell lung cancer

Xin Zhou, Shi Yan, Xiaopan Ma, Hua Zhu, Bing Liu, Xin Yang, Bing Jia, Zhi Yang, Nan Wu, Nan Li iD

European Journal of Nuclear Medicine and Molecular Imaging · 2025

DOI: 10.1007/s00259-025-07115-3 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von Xin Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Resea…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, B7-H1 Antigen, Lung Neoplasms, Immunotherapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Hospitals Authority's Ascent Plan, Capital's Funds for Health Improvement and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungB7-H1 AntigenLung NeoplasmsImmunotherapyHumansMaleFemaleMiddle AgedPositron Emission Tomography Computed TomographyAgedAdultGallium RadioisotopesTreatment OutcomeIsotope Labeling

Stichwörter der Autor:innen

68Ga-THP-APN09Neoadjuvant immunotherapyPET/CTResectable NSCLCToripalimab

Substanzen

B7-H1 AntigenCD274 protein, humanGallium Radioisotopes

Autor:innen und Institutionen

  • State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Nuclear Medicine, NMPA Key Laboratory for Research…
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, No. 52 Fucheng Rd., Beijing, 100142, China.
  • Department of Nuclear Medicine, Affiliated Hospital of Hubei, Xiangyang Central Hospital, University of Arts and Science, Xiangyang, 441138, China.
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Medical Isotopes Research Center, Department of Radiation Medicine, School of Basic Medical Sciences, Peking University, No.38 Xueyuan Rd, Beijing, 100191, China. jiabing@bjmu.edu.cn.
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, No. 52 Fucheng Rd., Beijing, 100142, China.…

ORCID-Profile: Nan Li

Förderung

  • National Natural Science Foundation of China
  • Beijing Hospitals Authority's Ascent Plan
  • Capital's Funds for Health Improvement and Research
  • Beijing Research Ward Excellence Program
  • National Key Research and Development Program
  • Beijing Natural Science Foundation
  • Science Foundation of Peking University Cancer Hospital
  • National Ten-thousand Talent Program

Zitieren

APA

Zhou, X., Yan, S., Ma, X., Zhu, H., Liu, B., Yang, X., Jia, B., Yang, Z., Wu, N., & Li, N. (2025). Efficacy of radiolabelled PD-L1-targeted nanobody in predicting and evaluating the combined immunotherapy and chemotherapy for resectable non-small cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07115-3

Vancouver

Zhou X, Yan S, Ma X, Zhu H, Liu B, Yang X, et al. Efficacy of radiolabelled PD-L1-targeted nanobody in predicting and evaluating the combined immunotherapy and chemotherapy for resectable non-small cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.1007/s00259-025-07115-3

BibTeX
@article{Zhou2025,
  author = {Zhou, Xin and Yan, Shi and Ma, Xiaopan and Zhu, Hua and Liu, Bing and Yang, Xin and Jia, Bing and Yang, Zhi and Wu, Nan and Li, Nan},
  title = {Efficacy of radiolabelled PD-L1-targeted nanobody in predicting and evaluating the combined immunotherapy and chemotherapy for resectable non-small cell lung cancer},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2025},
  doi = {10.1007/s00259-025-07115-3}
}
Kostenlos starten →